Nanobiotix S.A. ADR
Price
Key statistics
- Forward rate
- $0.00
- Yield
- 0.00%
- Payout ratio
- 0.00%
- Frequency
- Unknown
Nanobiotix S.A. ADR is a biotechnology company focused on developing nanomedicine-based approaches for cancer treatment. The company’s current activities center on its proprietary physics-based technology platform, which is designed to enhance the effect of radiotherapy by targeting tumor cells more precisely. Its lead therapeutic candidate is being developed for use across several oncology settings, including solid tumors and other difficult-to-treat cancers. Nanobiotix serves the healthcare and life sciences market through research, clinical development, and potential commercialization of advanced cancer therapies, with a business model built around product candidates that integrate with existing treatment protocols. Headquartered in Paris, France, Nanobiotix operates as a clinical-stage company with a focus on oncology innovation and translational medical science.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Laurent Levy Ph.D.
- Employees
- 100
- Headquarters
- Paris, France
- Website
- www.nanobiotix.com